These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 9988257)
21. DNA patenting: the end of an era? Hopkins MM; Mahdi S; Patel P; Thomas SM Nat Biotechnol; 2007 Feb; 25(2):185-7. PubMed ID: 17287750 [TBL] [Abstract][Full Text] [Related]
22. In search of a compromised solution to the problem arising from patenting biomedical research tools. Derzko NM Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840 [No Abstract] [Full Text] [Related]
23. Patenting medical thoughts. Rakatansky H R I Med; 1995 May; 78(5):128. PubMed ID: 7606057 [No Abstract] [Full Text] [Related]
24. The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovation. Gold ER; Adams W; Castle D; de Langavant GC; Cloutier LM; Daar AS; Glass A; Smith PJ; Bernier L Public Aff Q; 2004 Oct; 18(4):299-344. PubMed ID: 15812959 [No Abstract] [Full Text] [Related]
25. Patenting life: a view from the constitution and beyond. Schneider CA; Cohn F; Bonner C Whittier Law Rev; 2002; 24(2):385-416. PubMed ID: 15085853 [No Abstract] [Full Text] [Related]
26. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany. Schrell A; Bauser H; Brunner H Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818 [TBL] [Abstract][Full Text] [Related]
27. Patenting DNA and amino acid sequences--an Australian perspective. Keays D Health Law J; 1999; 7():69-90. PubMed ID: 11066370 [No Abstract] [Full Text] [Related]
30. Ownership of knowledge--the role of patents in pharmaceutical R&D. Correa CM Bull World Health Organ; 2004 Oct; 82(10):784-7; discussion 787-90. PubMed ID: 15643801 [TBL] [Abstract][Full Text] [Related]
31. Patents: patenting of stem cell related inventions in Europe. Rutz B; Yeats S Biotechnol J; 2006 Apr; 1(4):384-7. PubMed ID: 16892264 [No Abstract] [Full Text] [Related]
34. Churches say no to gene patenting. Christ Century; 2000 Sep; 117(25):899-900. PubMed ID: 12528735 [No Abstract] [Full Text] [Related]
35. Patenting the obvious? Check E Nature; 2007 May; 447(7140):16-7. PubMed ID: 17476235 [No Abstract] [Full Text] [Related]
36. More blockbusters on the way. Pharmaceutical spending and the impact of pipeline drugs. Kaddis A Mich Health Hosp; 2001; 37(5):20-3. PubMed ID: 11569284 [TBL] [Abstract][Full Text] [Related]
37. ACOG. Committee opinion: number 277, November 2002. Patients, medicine and the interests of patients: applying general principles to gene patenting. Comittee on Ethics, Comittee on Genetics, The American College of Obstetrician and Gynecologists Obstet Gynecol; 2002 Nov; 100(5 Pt 1):1051-6. PubMed ID: 12434779 [TBL] [Abstract][Full Text] [Related]
38. The gene patenting controversy: a convergence of law, economic interests, and ethics. Kevles DJ; Berkowitz A Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549 [No Abstract] [Full Text] [Related]
39. The patenting of novel biotech products. Webber PM IDrugs; 2007 Jul; 10(7):459-62. PubMed ID: 17642015 [TBL] [Abstract][Full Text] [Related]
40. ACLU lawsuit questions the patenting of breast cancer genes. Printz C Cancer; 2009 Nov; 115(21):4887-8. PubMed ID: 19842208 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]